pharmaphorum

FEBRUARY 9, 2022

The digitalisation that we all experience daily has affected the way we engage with stakeholders and patients. But how can we make Customer Engagement effective, and how can we leverage technologies like AI and Marketing Automation to their best potential? AiDEA Marketing – One conversation, multiple channels!

105

105

pharmaphorum

FEBRUARY 23, 2022

As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. The post 2nd Annual Gene Therapy Patient Engagement Summit appeared first on.

FDA 52

FDA 52

pharmaphorum

DECEMBER 15, 2022

With millions of HCPs using social media on a regular basis worldwide, engaging with them on one of these platforms should be a no-brainer. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media. Rather, they aim to educate and engage their followers. Healthcare Provider (HCP) marketing.

Communication 103

Communication Vaccines FDA 103

pharmaphorum

JUNE 1, 2022

Using just a headset, the user can be placed into a learning environment where they can perform tasks safely without risk, or they can be provided with a more engaging learning environment. When an individual’s health literacy on a given topic is poor, they become susceptible to misinformation.

Vaccines 145

Vaccines Immunization Hospitals Packaging 145

PQA

SEPTEMBER 1, 2022

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals. healthcare system for virtual clinical pharmacist incorporation into medical teams.

Documentation 52

Documentation 52

pharmaphorum

APRIL 30, 2021

We take a look at all these intersecting topics in this issue – with experts from across the industry sharing their advice on how companies can navigate these paradigm shifts. Turning words into actions with patient engagement. Research predicts the post-COVID landscape for HCP engagement.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 98

Viseven

JUNE 21, 2023

As one of the prominent providers of martech services in the pharmaceutical and life sciences industries, Viseven always tends to know what’s next for content development, omnichannel engagement, and customer experience. After visiting the NEXT Pharma Summit, we know better how we can uplift the level of customer engagement at Viseven.’

Communication 52

Communication 52

DiversifyRx

MARCH 16, 2023

Staff meetings are an opportunity to gain more team engagement, discuss new and upcoming initiatives, collaborate on ideas, learn what’s working and what’s not, and uncover any customer service issues that need attention. The key is to create staff meetings that are engaging, positive, and productive.

Customer Service 98

Customer Service Independent Pharmacies Documentation Communication 98

ISPE

MARCH 22, 2023

22 March 2023 The Biopharmaceutical industry continues to grow and deliver life-changing medicines to patients as evidenced by the number of drug approvals by the FDA year after year. The conference is expected to attract delegates from across the globe and promises very engaging and informative discussions and networking sessions.

FDA 98

FDA 98

pharmaphorum

OCTOBER 6, 2022

The new version – dubbed Florence 2.0 – covers a broader range of topics. The topics chosen for Florence are some of those that have the greatest burden on health around the world, and according to her developers she could help support healthcare workers in areas where there are shortages in healthcare staff.

Vaccines 145

Vaccines 145

Pharma Marketing Network

JULY 19, 2023

By creating and distributing valuable content, businesses can attract and engage their target audience, position themselves as experts in their field, and build trust with potential customers. This information could be valuable to potential patients who are considering taking the drug, and it could help the company attract new leads.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JUNE 30, 2022

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Patient access.

Communication 63

Communication 63

ISPE

MAY 16, 2023

Additionally, as per a survey conducted by Pistoia Alliance, 70 percent of survey participants thought blockchain has the potential to make a real difference in patient data management and sharing. Below are just a few of the topics that we’ve covered recently. Below are just a few of the topics that we’ve covered recently.

Compounding 98

Compounding 98

pharmaphorum

FEBRUARY 17, 2022

Understanding the person behind the patient is a crucial part of medicine, one that healthcare providers can use to improve the efficacy of treatments. At the 2021 Frontiers Health conference in Milan, Mark Duman and Paul Tunnah discuss the importance of co-creating with patients.

52

52

ISPE

SEPTEMBER 15, 2023

The Regulatory, Compliance, and Quality sessions, promise to be a comprehensive exploration of the vital topics shaping the pharmaceutical landscape. This fusion has the potential to revolutionize patient care, offering novel solutions that were once beyond reach.

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies Patient Care 98

PQA

AUGUST 29, 2022

PQA’s research areas include medication adherence, medication access and social determinants of health, patient engagement and pharmacy services. In addition to providing evidence to support quality measures before and after development, the team collaborates with PQA members to examine topics within PQA’s four primary research areas.

Community Pharmacies 52

Community Pharmacies 52

The FDA Law Blog

NOVEMBER 17, 2022

patients are “first in the world” to receive innovative medical devices that are of “high-quality, safe, and effective” through “early, frequent, and strategic communications between the FDA and medical device sponsors.” Food & Drug Admin., Total Product Life Cycle Advisory Program (TAP) (Oct. 11, 2022) [hereinafter “ Program Website ”].

Communication 69

Communication FDA 69

pharmaphorum

JANUARY 19, 2021

A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials. With low and geographically dispersed patient populations in rare disease, deciding where best to place trial sites can be a headache for sponsors.

Adverse Reactions 133

Adverse Reactions Communication Hospitals Compounding 133

pharmaphorum

JANUARY 25, 2023

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021. When are you ready?’.”

Dosage 104

Dosage FDA 104

pharmaphorum

AUGUST 18, 2022

Many different DTx offerings are in the field, being used by patients and prescribed by physicians, backed by rigorous scientific evidence. Prioritising patient perspectives. Patient centricity is important in every aspect of care, but the nature of digital therapeutics makes the topic especially germane, Coder says. “I’m

98

98

pharmaphorum

NOVEMBER 5, 2020

After three brushes with cancer, Robert Weker understands the patient journey more than many – and he is determined to put that experience to good use. My broad ambition is to get medicines and medical solutions that are more accessible, more affordable, and available in a more timely, more patient friendly way.”. “I

Chemotherapy 110

Chemotherapy Insurance Hospitals 110

The FDA Law Blog

NOVEMBER 21, 2022

patients are “first in the world” to receive innovative medical devices that are of “high-quality, safe, and effective” through “early, frequent, and strategic communications between the FDA and medical device sponsors.” Food & Drug Admin., Total Product Life Cycle Advisory Program (TAP) (Oct. 11, 2022) [hereinafter “ Program Website ”].

Communication 59

Communication FDA 59

Pharma Marketing Network

FEBRUARY 16, 2021

Some changes include relationships between patients and HCPs, how patients visit doctors, and especially how pharmaceutical and healthcare conferences are hosted. Now that we are in 2021 and virtual events are here to stay, here are some tips on how to continue increasing your online engagement when hosting virtual events.

Communication 98

Communication 98

ISPE

JUNE 23, 2023

Presentations will discuss harmonized approaches to advancements in drug development, design and equipment solutions, and project delivery strategies to ensure that quality therapeutic products are brought to market in an efficient and sustainable manner to improve patient health.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

Pharmaceutical Technology

SEPTEMBER 9, 2022

Gatehouse Bio is engaged in developing small RNA-based therapeutics using AI technology. Gatehouse Bio chief business officer Neal Foster said: “Our ability to identify small RNA mutations opens a novel class of targetable biology and an opportunity for a portfolio of oligonucleotide therapeutics that target specific groups of patients.”.

Compounding 98

Compounding 98

pharmaphorum

DECEMBER 3, 2021

The target is to actively engage with over 50,000 NHS workers from across the UK in the academy’s first year, and to improve the skills of all health and care professionals (HCPs) by 2031. More than third (37%) of those polled were also HCPs themselves. More than third (37%) of those polled were also HCPs themselves.

120

120

DiversifyRx

MARCH 22, 2024

If your current patient base isn’t the one you want, then focus on the type of patients and customers you do want. I often hear, ‘But my patients are “this” ’ Then targeted marketing will help you attract a different/better patient type and is even more important for you.

Independent Pharmacies 52

Independent Pharmacies Customer Service Packaging Communication 52

pharmaphorum

DECEMBER 22, 2020

But how has the push to develop treatments and vaccines for SARS-CoV-2 affected the industry’s commitment to patient centricity? This time last year, researchers and industry players were working hard to embed patient centricity and engagement into their everyday work. Green shoots of engagement. Widespread interest.

Vaccines 81

Vaccines 81

DiversifyRx

AUGUST 4, 2023

From cooking classes that teach you new healthy recipes to yoga classes that improve your flexibility and balance, educational sessions improve health and well-being, and they offer a chance to connect with like-minded individuals and learn from their experiences, making learning more engaging and enjoyable. Tap into niche markets.

Independent Pharmacies 52

Independent Pharmacies Compounding Hospitals 52

PharmaShots

JANUARY 23, 2023

The specific mechanisms by which VTAMA cream exerts its therapeutic action in psoriasis patients are unknown. Until recently, there were very few topical options available for treating plaque psoriasis long-term. of VTAMA cream? i] It does not contain any fragrance, petroleum jelly, para-aminobenzoic acid (PABA), parabens or gluten.

FDA 40

FDA Labelling Immunization 40

The FDA Law Blog

AUGUST 7, 2023

Through ELP, CDRH staff visit sites that provide formal training and enhance understanding on topics such as how products are developed and how they fit into the larger healthcare system. It was also helpful to hear first-hand the practical challenges companies navigate in bringing products to market.

Documentation 40

Documentation Insurance FDA 40

The FDA Law Blog

MARCH 1, 2023

FDA’s 2022 presentation and the information in the FDA’s 2023 paper on the QMM Pilot Programs are similar, but the paper provides more detail on what general aspects were assessed (referred to as practice areas) and the topics within those practice areas. Gallen and the Parenteral Drug Association (PDA).

Dosage 45

Dosage FDA 45

Pharma Marketing Network

APRIL 5, 2023

It’s worth repeating the industry mantra of reaching the right person, at the right time is still a core tenet in overarching customer engagement models. Marketing and analytics teams’ collaboration is critical in building more data-driven omnichannel engagement of HCPs and patients.

52

52

IDStewardship

MARCH 23, 2023

In this article three infectious diseases pharmacists discuss the cross-roads of antimicrobial resistance and microbiology laboratory, reflecting on a recent Twitter chat on the topic. AMR is scary and means many things to different people.

Hospitals 157

Hospitals Communication Patient Care 157

pharmaphorum

NOVEMBER 1, 2021

How can pharma move from a product- to a patient-centric mindset? Patient centricity isn’t a box ticking exercise – it’s a mindset that has to run the entire length of the drug development pathway. It’s important to remember, she said, that without patients, the pharma industry would not exist.

Communication 88

Communication 88

pharmaphorum

DECEMBER 22, 2021

Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action. Embedding the patient voice into research is also essential – it is the only way new treatments will be tailored to patients, their priorities, and their needs, she said.

Documentation 105

Documentation 105

Pharma Marketing Network

NOVEMBER 11, 2020

These changes include marketing processes, customer engagement, tools and tactics. . After one year of testing, results showed that highly targeted content increased engagement. These impacts include the expansion of virtual and digital engagements, shifting patient attitudes toward care, and internal company dynamics. .

Communication 52

Communication 52